Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain EXAS message board posts where the ticker symbol EXAS has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest EXAS SEC Filings

Filings Format Description Filing Date File/Film Number
CT ORDER  Documents Confidential treatment order
Acc-no: 9999999997-18-007239 (34 Act)  Size: 11 KB
2018-08-13 000-32179
181010451
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001558370-18-006112 (34 Act)  Size: 10 MB
2018-08-01 001-35092
18985676
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-044765 Size: 4 KB
2018-08-01
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-044763 Size: 4 KB
2018-08-01
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-044762 Size: 4 KB
2018-08-01
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-044761 Size: 4 KB
2018-08-01
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001104659-18-048759 (34 Act)  Size: 156 KB
2018-08-01 001-35092
18985093
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-044638 Size: 11 KB
2018-07-31
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-044486 Size: 4 KB
2018-07-30
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-044485 Size: 7 KB
2018-07-30
More EXAS SEC Filings


Related news from
Mon, 13 Aug 2018
13:00:00 +0000
Green Bay Packers and Cologuard Launch "Crossing the 50" Colon Cancer Awareness Campaign
GREEN BAY, Wis. and MADISON, Wis., Aug. 13, 2018 /PRNewswire/ -- When the Green Bay Packers cross the 50-yard line this season, it will be meaningful both on and off the field. Cologuard donates $50 to the Vince Lombardi Cancer Foundation each time the Green Bay Packers cross the 50-yard line this season. Fans taking colon cancer screening pledge at Packers50.com can be entered to win luxury box tickets.
Fri, 10 Aug 2018
19:17:06 +0000
GlycoMimetics Stock Has Substantial Upside
GlycoMimetics (NASDAQ:GLYC) issued a second quarter earnings report that investors will like. Its cash position was at high enough levels to cover future operational needs. GlycoMimetics ended the second quarter (Jun. 30, 2018) with $229.4 million in cash.
Fri, 10 Aug 2018
18:00:00 +0000
4 Biotech Stocks That May Fall By as Much as 13%
Biotech stocks have been hot since the beginning of May, rising by about 13% as measured by the iShares Nasdaq Biotechnology ETF ( IBB), more than double the pace of the S&P 500's rise. Shares of Intercept Pharmaceuticals Inc. ( ICPT) have risen by more than 63% since the beginning of May, while recently posting better-than-expected quarterly results that beat on both the top and bottom lines. The stock has run into a level of technical resistance around $118, posing as the first issue. Additionally, the relative strength index is showing signs that the stock is now overbought, rising above 70 three times since the start of June.
Thu, 09 Aug 2018
12:06:16 +0000
See what the IHS Markit Score report has to say about Exact Sciences Corp.
Exact Sciences Corp NASDAQ:EXAS
Mon, 06 Aug 2018
13:36:00 +0000
Is Exact Sciences a Buy on the Dip?
Did the latest market drubbing create a bargain opportunity?
Mon, 06 Aug 2018
10:00:00 +0000
Exact Sciences to participate in Canaccord Genuity Growth Conference
MADISON, Wis., Aug. 6, 2018 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that company management will be presenting at the following investor conference during August and invited investors to participate by webcast. The webcast can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com. Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer.
Fri, 03 Aug 2018
12:00:00 +0000
Today’s Research Reports on Stocks to Watch: DexCom and Exact Sciences
NEW YORK, NY / ACCESSWIRE / August 3, 2018 / DexCom and Exact Sciences Corporation went in separate directions after reporting second quarter results. DexCom exploded and hit a new high after reporting an earnings beat while Exact Sciences slipped almost 13% after missing its revenue expectations. DexCom, Inc. shares closed up 30.65% on nearly 7 million shares traded.
Fri, 03 Aug 2018
09:35:47 +0000
Edited Transcript of EXAS earnings conference call or presentation 1-Aug-18 9:00pm GMT
Q2 2018 Exact Sciences Corp Earnings Call
Thu, 02 Aug 2018
17:30:27 +0000
Exact Sciences' stock drops sharply as Madison company misses analysts' projections
The company's stock dropped more than 10 points, or 21 percent, in after-hours trading, opening at $48.26.
Thu, 02 Aug 2018
15:00:00 +0000
Tom Lehman Joins Forces with Fight Colorectal Cancer to Raise Awareness of Nation's Second-Leading Cause of Cancer Deaths
BLAINE, Minn., Aug. 2, 2018 /PRNewswire/ -- Longtime PGA TOUR professional and colon cancer survivor, Tom Lehman, is teaming up with Fight Colorectal Cancer (Fight CRC) to help raise awareness of the nation's second-deadliest cancer. The one-year agreement, supported by Exact Sciences (EXAS), will feature Lehman wearing the Fight CRC logo on his hat, numerous public appearances, and a public service announcement campaign highlighting the importance of early detection and the options available for colon cancer screening, including accurate, non-invasive options.
Thu, 02 Aug 2018
11:19:01 +0000
Dow Jones Futures Fall On China Trade War Threat; Tesla Leads Big Earnings Movers
Stock futures fell on U.S.-China trade war fears: Tesla stock soared on cash levels and profitability plans, Wynn Resorts and Exact Sciences also moved on earnings.
Thu, 02 Aug 2018
10:31:00 +0000
Exact Sciences Misses Revenue Estimates by $1.8 Million -- But It Cost the Company a Lot More
The high-flying maker of Cologuard DNA tests fails to deliver in Q2 on sky-high revenue growth expectations.
Wed, 01 Aug 2018
21:37:31 +0000
Exact Sciences: 2Q Earnings Snapshot
On a per-share basis, the Madison, Wisconsin-based company said it had a loss of 30 cents. The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment ...
Wed, 01 Aug 2018
20:05:00 +0000
Cologuard® revenue increased 78 percent to $103 million during second quarter
- More than 10,000 healthcare providers ordered their initial Cologuard test during the second quarter, and nearly 121,000 have ordered since the test was launched MADISON, Wis. , Aug. 1, 2018 /PRNewswire/ ...
Wed, 25 Jul 2018
17:10:00 +0000
3 'Strong Buy' Healthcare Stocks Poised to Surge
Bring on healthcare earnings season. Ahead of earnings season for the group, we have selected three healthcare stocks beating the market in 2018. Using TipRanks' Stock Screener tool, we quickly discovered the best-rated stocks, filtering by "best analyst consensus" stocks in the healthcare sector.
Thu, 12 Jul 2018
11:25:00 +0000
Free Research Reports on DexCom and Three More Medical Research Stocks
Stock Research Monitor: CGIX, CHEK, and EXAS LONDON, UK / ACCESSWIRE / July 12, 2018 / If you want a free Stock Review on DXCM sign up now at www.wallstequities.com/registration . Today's research on WallStEquities.com ...
Mon, 09 Jul 2018
20:15:00 +0000
Exact Sciences to host annual meeting, second-quarter 2018 results webcasts and calls
MADISON, Wis. , July 9, 2018 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host webcasts and conference calls of its annual stockholders meeting and to discuss ...
Sat, 07 Jul 2018
11:15:00 +0000
Why Exact Sciences Shares Are Rallying 13.8% in 2018
Demand for its colon cancer screening solution continues to drive sales higher even as the company invests in next-generation screening.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "At VF I have met some of the greatest givers from all walks of life and from all parts of the world. I thank each of them for sharing part of their life and knowledge with me." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards